Clinical Trials Logo

Traumatic Arthritis clinical trials

View clinical trials related to Traumatic Arthritis.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05787821 Recruiting - Clinical trials for Rheumatoid Arthritis

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Start date: June 28, 2023
Phase:
Study type: Observational

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty

NCT ID: NCT05773352 Recruiting - Traumatic Arthritis Clinical Trials

Perform® Humeral System - Fracture Study (PFX)

PFX
Start date: August 31, 2023
Phase:
Study type: Observational

This study is an international, single arm, multicenter, prospective follow-up, non-significant risk, Post-Market Clinical Follow-up (PMCF), which is designed to collect safety and performance data on commercially available Perform® Fracture. Data collected from this study will be used for purposes, including but not limited to, PMS, peer-reviewed publications, education materials, future regulatory submissions, and/or product development.

NCT ID: NCT05679232 Recruiting - Arthritis Clinical Trials

Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty

Start date: December 6, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized, controlled, monocentric, single-blind, 2-arm, feasibility clinical investigation is to evaluate the safety of MectaShield hydrogel coating and to capture its preliminary clinical performance in the prevention of early peri-prosthetic joint infection (PJI) in patients undergoing cementless revision hip arthroplasty. The main questions it aims to answer are: - demonstrate that the hydrogel coating MectaShield does not interfere with primary stability; - evaluate clinical and functional outcomes, the rate of PJI and possible adverse events. Participants will undergo cementless revision hip arthroplasty; during surgery MectaShield hydrogel coating is applied on orthopaedic implants' surfaces (femoral stem and, if revised, acetabular cup) as a protective barrier for the prevention of bacterial adhesion. Surgery and follow-up are completed as per local standard practice. Stability will be assessed radiologically, while functional outcomes and PJI will be monitored by HOOS-PS, ASESPIS scores and according to the consensus document presented by European Society of Radiology (ESRa), the European Association of Nuclear Medicine (EANM), the European Bone and Joint Infection Society (EBJIS), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Researchers will compare the results of the treatment group with those from a control group receiving cementless revision hip arthroplasty without the application of MectaShiled hydrogel coating.

NCT ID: NCT05630053 Recruiting - Clinical trials for Rheumatoid Arthritis

Cemented vs Cementless Persona Keel RCT

Start date: July 25, 2023
Phase: N/A
Study type: Interventional

The main objective of this study is to evaluate the safety, performance, and clinical benefits of the Persona Keel cementless and cemented knee.

NCT ID: NCT05460715 Recruiting - Traumatic Arthritis Clinical Trials

The Medacta Quadra-P Anteverted Study

Start date: July 30, 2021
Phase:
Study type: Observational

This is a Post-Marketing Surveillance of Quadra-P anteverted stem prosthesis.

NCT ID: NCT05003414 Recruiting - Clinical trials for Rheumatoid Arthritis

The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study

Start date: January 14, 2020
Phase:
Study type: Observational

This is a Post-Marketing Surveillance study of GMK Sphere cementless knee prosthesis.

NCT ID: NCT03048201 Recruiting - Clinical trials for Rheumatoid Arthritis

Physica System Total Knee Replacement Registry Study

Start date: March 24, 2017
Phase: N/A
Study type: Interventional

The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.

NCT ID: NCT02783274 Recruiting - Clinical trials for Rheumatoid Arthritis

Actis Total Hip System 2 Year Follow-up

Actis14014
Start date: July 1, 2016
Phase: N/A
Study type: Interventional

Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.

NCT ID: NCT02748408 Recruiting - Traumatic Arthritis Clinical Trials

The Medacta International SMS Post-Marketing Surveillance Study

Start date: July 2015
Phase:
Study type: Observational

This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.

NCT ID: NCT01542580 Recruiting - Clinical trials for Rheumatoid Arthritis

A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

Start date: March 2012
Phase:
Study type: Observational

The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.